Researchers describe the symptom profiles of respiratory viral infections.
Gut-Friendlier Dose of Nintedanib Finally Backed by Some Data
HONOLULU — A reduced-dose regimen of the antifibrotic medication nintedanib (Ofev) held up in real-world clinical practice, an observational study found. Approved for the treatment